港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

醫美概念股

617.971

+4.2550.69%

漲家數：10

跌家數：2

平家數：1

市盈率：- -

高：624.136

開：613.521

低：609.693

收：613.715

資料載入中...

總覽新聞資訊

昊海生物科技(06826)3月4日斥資434.07萬元回購7.1萬股A股

復星醫藥：24價肺炎球菌多糖結合疫苗臨牀試驗獲批

復星醫藥(600196.SH)子公司獲24價肺炎疫苗臨牀試驗批准

復星醫藥：控股子公司獲24價肺炎球菌多糖結合疫苗臨牀試驗批准

瑞麗醫美盤中異動下午盤快速下挫5.13%

讀懂IPO|軒竹生物產品上市首年創收不足2000萬元，赴港IPO前夕遭12家機構股東退股

8款新藥在中國獲批上市 3款治療癌症！來自強生(JNJ.US)、復星醫藥(02196)等公司

智通财经网

昊海生物科技截至2月末累計回購A股66.25萬股

昊海生物科技股東樓國樑未減持公司股份減持計劃實施完畢

昊海生物科技(06826.HK)累計回購66.25萬A股總額4,054萬人民幣

阿斯达克财经

昊海生物科技(06826)股東樓國樑未減持公司股份減持計劃實施完畢

智通财经网

昊海生物科技(06826)截至2月末累計回購A股66.25萬股

完美醫療03月03日獲主力加倉135萬元

醫思健康完成出售New Medical Centre Holding Limited 51%股權

醫思健康(02138)完成出售New Medical Centre Holding Limited 51%股權

醫思健康(02138.HK)完成出售HKMAI TST不再計入集團財務報表

阿斯达克财经

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1593/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"醫美概念股","latestPrice":617.97076,"timestamp":1741248510330,"preClose":613.71533,"halted":0,"volume":73113617,"delay":0,"changeRate":0.006934,"change":4.255432,"pbRate":1.187551,"amount":463944295,"amplitude":0.023533,"prevYearClose":571.87146,"fiveDayClose":630.978,"twentyDayClose":569.947,"turnoverRate":0.003523,"marketCap":111331486452,"floatMarketCap":73298803508,"peRate":21.508467},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":624.1355,"amplitude":0.023533,"preClose":613.71533,"low":609.69275,"pbRate":"1.187551","latestPrice":617.97076,"volume":73113617,"delay":0,"open":613.5211,"prevYearClose":571.87146,"prevWeekClose":612.07,"prevMonthClose":612.07,"prevQuarterClose":571.871,"fiveDayClose":630.978,"twentyDayClose":569.947,"sixtyDayClose":585.06,"secType":"PLATE","market":"HK","turnoverRate":0.003523,"peRate":21.508467,"marketCap":111331486452,"floatMarketCap":73298803508,"timestamp":1741248510330,"nameCN":"醫美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":10,"down":2,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:16,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516628195","title":"昊海生物科技(06826)3月4日斥資434.07萬元回購7.1萬股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2516628195","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516628195?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 17:21","pubTimestamp":1741080109,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，于2025年3月4日，该公司斥资434.07万元回购7.1万股A股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257533.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1593","159982","399300","06826"],"gpt_icon":0},{"id":"2517605039","title":"復星醫藥：24價肺炎球菌多糖結合疫苗臨牀試驗獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2517605039","media":"E公司","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517605039?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 17:09","pubTimestamp":1741079346,"startTime":"0","endTime":"0","summary":"人民财讯3月4日电，复星医药(600196)3月4日晚间公告，控股子公司复星安特金（成都）生物制药有限公司（简称“复星安特金”）于近日收到国家药品监督管理局关于24价肺炎球菌多糖结合疫苗的临床试验批准。复星安特金拟于条件具备后于中国境内（不包括港澳台地区）开展该疫苗的I期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304170906989b4833&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304170906989b4833&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1583","BK1593","BK1191","03347","BK1141","BK1576","02196"],"gpt_icon":0},{"id":"2516404936","title":"復星醫藥(600196.SH)子公司獲24價肺炎疫苗臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2516404936","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516404936?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 17:01","pubTimestamp":1741078876,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药 发布公告，公司控股子公司复星安特金(成都)生物制药有限公司于近日收到国家药品监督管理局关于24价肺炎球菌多糖结合疫苗的临床试验批准。复星安特金拟于条件具备后于中国境内开展该疫苗的I期临床试验。该疫苗采用集团拥有自主知识产权的平台技术将多糖抗原与载体蛋白结合，可以在6周龄及以上人群体内诱导产生针对多糖的T细胞依赖性免疫应答及免疫记忆。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257509.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0175","BK0183","02196","BK1583","BK0188","600196","BK1576","BK1141","BK1515","BK0196","BK1191","BK0060","BK0096","03347","BK0187","159646","BK0239","BK0012","BK1593"],"gpt_icon":0},{"id":"2516664039","title":"復星醫藥：控股子公司獲24價肺炎球菌多糖結合疫苗臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2516664039","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516664039?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 16:59","pubTimestamp":1741078785,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0028","BK0187","BK1593","BK0096","03347","BK0196","BK1141","BK0012","BK0239","BK0188","BK1515","BK1583","BK0060","BK1191","BK0175","600196","BK0183","159646","BK1576","02196"],"gpt_icon":0},{"id":"2516614076","title":"瑞麗醫美盤中異動 下午盤快速下挫5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516614076","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516614076?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 13:39","pubTimestamp":1741066758,"startTime":"0","endTime":"0","summary":"2025年03月04日下午盘13时39分，瑞丽医美股票出现异动，股价快速跳水5.13%。截至发稿，该股报0.111港元/股，成交量22万股，换手率0.04%，振幅0.85%。瑞丽医美股票所在的医疗及医学美容服务行业中，整体涨幅为0.43%。其相关个股中，讯飞医疗科技、固生堂、平安好医生涨幅较大，振幅较大的相关个股有亮晴控股、一脉阳光、健康之路，振幅分别为20.27%、12.64%、9.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030413391896389fba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030413391896389fba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02135","BK1209","BK1593"],"gpt_icon":0},{"id":"2516613021","title":"讀懂IPO|軒竹生物產品上市首年創收不足2000萬元，赴港IPO前夕遭12家機構股東退股","url":"https://stock-news.laohu8.com/highlight/detail?id=2516613021","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516613021?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 11:17","pubTimestamp":1741058267,"startTime":"0","endTime":"0","summary":"对于零收入的创新药公司而言，研发管线的商业化进程和前景是攸关生死的。作为四环医药（00460.HK）旗下的创新药研发平台，轩竹生物科技股份有限公司（下称“轩竹生物”）于2024年5月撤回科创板IPO申请材料，2024年11月转而向港交所递表并获受理。截至目前，该公司尚未通过聆讯。招股书显示，轩竹生物的三款核心产品中，已有一款于2023年6月获批上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503043335834010.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","ALK","BK1593","BK1600","00460","BK1515","BK4585","BK4588","BK4570","BK4008","BK4500","PPI"],"gpt_icon":0},{"id":"2516976056","title":"8款新藥在中國獲批上市 3款治療癌症！來自強生(JNJ.US)、復星醫藥(02196)等公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2516976056","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516976056?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 10:04","pubTimestamp":1741053893,"startTime":"0","endTime":"0","summary":"根据中国国家药监局（NMPA）官网及公开信息，在刚刚过去的2025年2月，至少有8款新药*在中国获批上市。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20250304/20250304100615_92313.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20250304/20250304100615_92313.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU2129689605.HKD","BK0096","IE00BGHQF631.EUR","BK1515","BK4588","LU1718418525.SGD","BK0028","LU1244550494.USD","LU1221951046.USD","LU1261432733.SGD","SG9999001440.SGD","LU2430703095.HKD","BK4592","LU1032955483.USD","LU0234572021.USD","IE00B1BXHZ80.USD","LU0466842654.USD","LU1059921491.USD","LU1032466523.USD","02196","LU0882574055.USD","LU2468319806.SGD","LU1732799900.SGD","IE0002270589.USD","600196","BK0175","LU1430594728.SGD","BK1593","LU1585245621.USD","LU0795875086.SGD","BK1191","IE00BJT1NW94.SGD","IE00B19Z3B42.SGD","LU0234570918.USD","IE00BSNM7G36.USD","LU1778281490.HKD","LU1023059063.AUD","LU2602419157.SGD","LU1267930813.SGD","LU1894683348.USD","LU0058720904.USD","JNJ","LU1061106388.HKD","LU2430703178.SGD","BK4559","LU1929549753.HKD","LU2592432038.USD","BK4532","IE00B2B36J28.USD","LU2505996509.AUD"],"gpt_icon":1},{"id":"2516956056","title":"昊海生物科技截至2月末累計回購A股66.25萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2516956056","media":"新浪港股","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516956056?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 08:33","pubTimestamp":1741048380,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　昊海生物科技（06826）发布公告，2025年2月，公司未实施股份回购。截至2025年2月28日，公司通过集中竞价交易方式累计回购公司A股股份66.25万股，占公司总股本2.33亿股的比例为0.28%，最高成交价为63.58元/股，最低成交价为56.78元/股，成交总金额为4053.64万元（不含印花税、交易佣金等交易费用）。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-03-04/doc-inenmxpq5931234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1593","06826","159982","399300","BK1161"],"gpt_icon":0},{"id":"2516695657","title":"昊海生物科技股東樓國樑未減持公司股份 減持計劃實施完畢","url":"https://stock-news.laohu8.com/highlight/detail?id=2516695657","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516695657?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 08:32","pubTimestamp":1741048320,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　昊海生物科技（06826）公布，公司于 2025 年 3 月 3 日收到楼国梁先生出具的《关于股份减持结果的告知函》，截至 2025 年 3 月 3 日，本次股份减持计划时间届满，楼国梁先生未减持公司股份，本次减持计划实施完毕。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-03-04/doc-inenmxpt8843940.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06826","BK1593","BK1161"],"gpt_icon":0},{"id":"2516658906","title":"昊海生物科技(06826.HK)累計回購66.25萬A股  總額4,054萬人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658906","media":"阿斯达克财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516658906?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 23:50","pubTimestamp":1741017000,"startTime":"0","endTime":"0","summary":"昊海生物科技(06826.HK) 公布，2月28日止，累计回购66.25万股A股，占总股本0.28%；每股作价介乎56.78-63.58元人民币，总金额约4,054万人民币。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-03 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230627125933138_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230627125933138_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1421730/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06826","BK1593","BK1161","399300","159982"],"gpt_icon":0},{"id":"2516968077","title":"昊海生物科技(06826)股東樓國樑未減持公司股份 減持計劃實施完畢","url":"https://stock-news.laohu8.com/highlight/detail?id=2516968077","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516968077?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 20:28","pubTimestamp":1741004884,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)公布，公司于 2025 年 3 月 3 日收到楼国梁先生出具的《关于股份减持结果的告知函》，截至 2025 年 3 月 3 日，本次股份减持计划时间届满，楼国梁先生未减持公司股份，本次减持计划实施完毕。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257149.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1593","BK1161","06826"],"gpt_icon":0},{"id":"2516801316","title":"昊海生物科技(06826)截至2月末累計回購A股66.25萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2516801316","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516801316?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 20:19","pubTimestamp":1741004372,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，2025年2月，公司未实施股份回购。截至2025年2月28日，公司通过集中竞价交易方式累计回购公司A股股份66.25万股，占公司总股本2.33亿股的比例为0.28%，最高成交价为63.58元/股，最低成交价为56.78元/股，成交总金额为4053.64万元(不含印花税、交易佣金等交易费用)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257139.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399300","BK1161","159982","BK1593","06826"],"gpt_icon":0},{"id":"2516950001","title":"完美醫療03月03日獲主力加倉135萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516950001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516950001?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 16:17","pubTimestamp":1740989827,"startTime":"0","endTime":"0","summary":"03月03日，完美医疗股价收平报2.15元，成交金额452万元，换手率0.17%，振幅3.26%，量比4.21。完美医疗今日主力资金净流入135万元，上一交易日主力净流入18万元。该股近5个交易日下跌0.92%，主力资金累计净流入153万元；近20日主力资金累计净流入174万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303165449abe5c324&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303165449abe5c324&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1215","01830"],"gpt_icon":0},{"id":"2516875571","title":"醫思健康完成出售New Medical Centre Holding Limited 51%股權","url":"https://stock-news.laohu8.com/highlight/detail?id=2516875571","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516875571?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 12:55","pubTimestamp":1740977700,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　医思健康（02138）发布公告，出售事项已根据购股协议的条款及条件于2025年2月28日完成。收购事项亦已根据收购协议的条款及条件于2025年2月5日完成。于出售事项及收购事项完成后，公司不再拥有目标集团（包括HKMAI TST）任何权益。目标集团成员公司（包括HKMAI TST）不再为公司的附属公司，其财务业绩将不再综合计入集团的财务报表。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-03-03/doc-ineniywq0910501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1215","BK1511","02138","BK1593"],"gpt_icon":0},{"id":"2516579898","title":"醫思健康(02138)完成出售New Medical Centre Holding Limited 51%股權","url":"https://stock-news.laohu8.com/highlight/detail?id=2516579898","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516579898?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 12:24","pubTimestamp":1740975853,"startTime":"0","endTime":"0","summary":"智通财经APP讯，医思健康(02138)发布公告，出售事项已根据购股协议的条款及条件于2025年2月28日完成。收购事项亦已根据收购协议的条款及条件于2025年2月5日完成。于出售事项及收购事项完成后，公司不再拥有目标集团(包括HKMAI TST)任何权益。目标集团成员公司(包括HKMAI TST)不再为公司的附属公司，其财务业绩将不再综合计入集团的财务报表。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256781.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1215","BK1511","BK1593","02138"],"gpt_icon":0},{"id":"2516553579","title":"醫思健康(02138.HK)完成出售HKMAI TST不再計入集團財務報表","url":"https://stock-news.laohu8.com/highlight/detail?id=2516553579","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516553579?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 12:21","pubTimestamp":1740975660,"startTime":"0","endTime":"0","summary":"医思健康(02138.HK) 公布，附属公司HKMAI TST的出售事项，已根据购股协议之条款及条件于上周五(2月28日)完成。至于收购事项亦已根据收购协议之条款及条件于今年2月5日完成。公告指，于出售事项及收购事项完成后，医思健康不再拥有HKMAI TST任何权益。HKMAI TST不再为该公司之附属公司，其财务业绩将不再综合计入集团之财务报表。(js/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210712124044055_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210712124044055_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1421564/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1511","BK1215","02138","BK1593"],"gpt_icon":0}],"pageSize":16,"totalPage":9,"pageCount":3,"totalSize":143}]}}